NEUROFIX INVERSORES
NEUROFIX COMPAÑÍA
ACTUALIDAD NEUROFIX
- Neurofix Pharma will participate in the major biotechnology events.24 de August de 2023 - 13:33
- Neurofix Pharma presents the successful results of its phase IIA clinical trial to institutions and businessmen in Salamanca28 de November de 2022 - 08:46
- Mañueco visits the offices of Neurofix Pharma, the first biotech company in Castilla y León to successfully complete phase IIA of a clinical trial11 de November de 2022 - 15:42
NEUROFIX CONTACT
University of Salamanca Science Park
Santibáñez del Río Street 2, M3 building , PB05, room 1
37185 Villamayor, Salamanca
Chamartín Station, first floor, no number
28036 Madrid (Spain)
Neurofix Pharma will participate in the major biotechnology events.
Neurofix Pharma presents the successful results of its phase IIA clinical trial to institutions and businessmen in Salamanca
Mañueco visits the offices of Neurofix Pharma, the first biotech company in Castilla y León to successfully complete phase IIA of a clinical trial
Neurofix Pharma enters the ‘club of the chosen ones’ by reaching the last phase of one of the most competitive EU calls.